Personalized medicine for schizophrenia

Código QR

Personalized medicine for schizophrenia

Guardado en:

Detalles Bibliográficos
Autores principales:	Peter F. Buckley, Brian J. Miller
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Psychiatry RC435-571
Acceso en línea:	https://doaj.org/article/6245f5eceead42838546c9638aed4a74
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Enabling point-of-care testing and personalized medicine for schizophrenia
por: Paul C. Guest, et al.
Publicado: (2017)

Science of recovery in schizophrenia research: brain and psychological substrates of personalized value
por: Kiyoto Kasai, et al.
Publicado: (2017)

Unravelling socio-motor biomarkers in schizophrenia
por: Piotr Słowiński, et al.
Publicado: (2017)

Schizophrenia genetics comes to translation
por: Enrico Domenici
Publicado: (2017)

What if it was easier to prevent schizophrenia than to treat it?
por: Kristen J. Brennand
Publicado: (2017)

The effect of sex on social cognition and functioning in schizophrenia
por: Marta Ferrer-Quintero, et al.
Publicado: (2021)

Investigating the effects of genetic risk of schizophrenia on behavioural traits
por: Adam Socrates, et al.
Publicado: (2021)

Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer’s disease and cognition
por: Brian Dean, et al.
Publicado: (2021)

On discontinuing treatment in schizophrenia: a clinical conundrum
por: Robin Emsley
Publicado: (2017)

Historical pursuits of the language pathway hypothesis of schizophrenia
por: Lynn E. DeLisi
Publicado: (2021)

The progression of disorder-specific brain pattern expression in schizophrenia over 9 years
por: Johannes Lieslehto, et al.
Publicado: (2021)

Reply to: “Historical pursuits of the language pathway hypothesis of schizophrenia”
por: Lena Palaniyappan, et al.
Publicado: (2021)

Accuracy of self-assessment of real-life functioning in schizophrenia
por: Paola Rocca, et al.
Publicado: (2021)

Association of visual motor processing and social cognition in schizophrenia
por: Pin-Yen Lu, et al.
Publicado: (2021)

Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
por: Nicolette Stogios, et al.
Publicado: (2021)

DNA methylation evidence against the accelerated aging hypothesis of schizophrenia
por: Brandon C. McKinney, et al.
Publicado: (2017)

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
por: Kazu Nakazawa, et al.
Publicado: (2017)

DNA methylation in schizophrenia in different patient-derived cell types
por: Alejandra M. Vitale, et al.
Publicado: (2017)

Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
por: Jonne Lintunen, et al.
Publicado: (2021)

Understanding communicative intentions in schizophrenia using an error analysis approach
por: Parola Alberto, et al.
Publicado: (2021)

Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity
por: Simon Fish, et al.
Publicado: (2021)

The impact of creativity on functional outcome in schizophrenia: a mediational model
por: Agurne Sampedro, et al.
Publicado: (2021)

Learning stable and predictive network-based patterns of schizophrenia and its clinical symptoms
por: Mina Gheiratmand, et al.
Publicado: (2017)

Progress in genome-wide association studies of schizophrenia in Han Chinese populations
por: Weihua Yue, et al.
Publicado: (2017)

Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
por: Gregory P. Strauss, et al.
Publicado: (2021)

Polygenic risk scores for late smoking initiation associated with the risk of schizophrenia
por: Kazutaka Ohi, et al.
Publicado: (2020)

Managing Recurrent Clozapine-Induced Constipation in a Patient with Resistant Schizophrenia
por: Silviu Tomulescu, et al.
Publicado: (2021)

Online Group Therapy Experience with Schizophrenia Patients During the Pandemic Period
por: Mehmet Buğrahan Gürcan, et al.
Publicado: (2021)

Isoform specific differences in phospholipase C beta 1 expression in the prefrontal cortex in schizophrenia and suicide
por: M. Udawela, et al.
Publicado: (2017)

Altered sulcogyral patterns of orbitofrontal cortex in a large cohort of patients with schizophrenia
por: Shuichi Isomura, et al.
Publicado: (2017)

The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia
por: Jingnan Du, et al.
Publicado: (2021)

Reduced intrinsic neural timescales in schizophrenia along posterior parietal and occipital areas
por: Lavinia Carmen Uscătescu, et al.
Publicado: (2021)

Multimodal assessment of communicative-pragmatic features in schizophrenia: a machine learning approach
por: Alberto Parola, et al.
Publicado: (2021)

Author Correction: Understanding communicative intentions in schizophrenia using an error analysis approach
por: Alberto Parola, et al.
Publicado: (2021)

Relationship of ventral striatum activation during effort discounting to clinical amotivation severity in schizophrenia
por: Greer E. Prettyman, et al.
Publicado: (2021)

Assessing the relationship between routine and schizophrenia symptoms with passively sensed measures of behavioral stability
por: Joy He-Yueya, et al.
Publicado: (2020)

Functional connectivity abnormalities of the long-axis hippocampal subregions in schizophrenia during episodic memory
por: Jules R. Dugré, et al.
Publicado: (2021)

Reduced cortical gyrification in the posteromedial cortex in unaffected relatives of schizophrenia patients with high genetic loading
por: Inkyung Park, et al.
Publicado: (2021)

Natural language processing methods are sensitive to sub-clinical linguistic differences in schizophrenia spectrum disorders
por: Sunny X. Tang, et al.
Publicado: (2021)

Impaired cerebro-cerebellar white matter connectivity and its associations with cognitive function in patients with schizophrenia
por: Sung Eun Kim, et al.
Publicado: (2021)